K
Keisei Kawa
Researcher at Boston Children's Hospital
Publications - 168
Citations - 8047
Keisei Kawa is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 45, co-authored 167 publications receiving 7377 citations. Previous affiliations of Keisei Kawa include Nagoya University & Osaka University.
Papers
More filters
Journal ArticleDOI
The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
Yasuo Morishima,Takehiko Sasazuki,Hidetoshi Inoko,Takeo Juji,Tatsuya Akaza,Ken Yamamoto,Yoshihide Ishikawa,Shunichi Kato,Hiroshi Sao,Hisashi Sakamaki,Keisei Kawa,Nobuyuki Hamajima,Shigetaka Asano,Yoshihisa Kodera +13 more
TL;DR: The role of the HLA class I allele in unrelated bone marrow transplantation was elucidated, and Notably, HLA-C alleles had a different mode from Hla-A or -B alleles for acute GVHD and survival.
Journal ArticleDOI
Clinical and virologic characteristics of chronic active Epstein-Barr virus infection
Hiroshi Kimura,Yo Hoshino,Hirokazu Kanegane,Ikuya Tsuge,Takayuki Okamura,Keisei Kawa,Tsuneo Morishima +6 more
TL;DR: In this paper, 30 patients with chronic active Epstein-Barr virus (CAEBV) infection were analyzed, and they were divided into two clinically distinct groups, based on whether the predominantly infected cells in their peripheral blood were T cells or natural killer (NK) cells.
Journal ArticleDOI
Nationwide survey of hemophagocytic lymphohistiocytosis in Japan.
Eiichi Ishii,Shouichi Ohga,Shinsaku Imashuku,Masaki Yasukawa,Hiroyuki Tsuda,Ikuo Miura,Ken Yamamoto,Hisanori Horiuchi,Kenzo Takada,Koichi Ohshima,Shigeo Nakamura,Naoko Kinukawa,Kazuo Oshimi,Keisei Kawa +13 more
TL;DR: Although this nationwide survey establishes the heterogeneous characteristics of HLH, the results should be useful in planning prospective studies to identify the most effective therapy for each HLH subtype.
Journal ArticleDOI
EBV-associated T/NK–cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases
Hiroshi Kimura,Yoshinori Ito,Shinji Kawabe,Kensei Gotoh,Yoshiyuki Takahashi,Seiji Kojima,Tomoki Naoe,Shinichi Esaki,Atsushi Kikuta,Akihisa Sawada,Keisei Kawa,Koichi Ohshima,Shigeo Nakamura +12 more
TL;DR: Age at onset of disease and liver dysfunction were risk factors for mortality, whereas patients who received transplantation had a better prognosis, and insight into the diagnostic and therapeutic approaches for distinct disease is provided.
Journal ArticleDOI
Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3
Dai Iwakiri,Li Zhou,Mrinal Samanta,Misako Matsumoto,Takashi Ebihara,Tsukasa Seya,Shosuke Imai,Mikiya Fujieda,Keisei Kawa,Kenzo Takada +9 more
TL;DR: It is reported that EBER induces signaling from the Toll-like receptor 3 (TLR3), which is a sensor of viral double-stranded RNA (dsRNA) and induces type I IFN and proinflammatory cytokines and EBER-induced activation of innate immunity would account for immunopathologic diseases caused by active EBV infection.